Alpha-1 Antitrypsin Mutation(Archived)
- PMID: 29489299
- Bookshelf ID: NBK482180
Alpha-1 Antitrypsin Mutation(Archived)
Excerpt
Alpha-1 antitrypsin is a protease inhibitor (PI) produced primarily in the liver. It inhibits the neutrophil elastase activity in the lung and protects it from proteolytic damage. It is responsible for approximately 90% of the protection against elastolytic activity in the lower airways caused by elastase released from neutrophils. If the neutrophils' elastases are not opposed, panacinar lung tissue is damaged, increasing the risk of developing chronic obstructive pulmonary disease (COPD). On the other hand, the retention and accumulation of mutated polymers in the endoplasmic reticulum of hepatocytes renders individuals with this disease at risk of "a gain of toxic function," leading to liver disease.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
References
-
- Comba A, Demirbaş F, Çaltepe G, Eren E, Kalayci AG. Retrospective analysis of children with α-1 antitrypsin deficiency. Eur J Gastroenterol Hepatol. 2018 Jul;30(7):774-778. - PubMed
-
- Esquinas C, Janciauskiene S, Gonzalo R, Mas de Xaxars G, Olejnicka B, Belmonte I, Barrecheguren M, Rodriguez E, Nuñez A, Rodriguez-Frias F, Miravitlles M. Gene and miRNA expression profiles in PBMCs from patients with severe and mild emphysema and PiZZ alpha1-antitrypsin deficiency. Int J Chron Obstruct Pulmon Dis. 2017;12:3381-3390. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous